Biotech articles
-
We Need to be Ready for Biotech’s ChatGPT Moment
Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes Eric Schmidt.
-
Reshape Biotech: Using robotics and AI to speed up lab experiments
Carl-Emil Grøn is the co-founder and CEO of one of the most exciting start-ups in Denmark. Now, with a recent funding boost and US expansion, he wants the full-stack company to start doing exactly what its name suggests. : Reshape Biotech: Using robotics and AI to speed up lab experiments
-
Moleculin Biotech (NASDAQ:MBRX) Research Coverage Started at StockNews.com
Stock analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock. MBRX has been the subject of several other reports. Maxim Group dropped their target price on Moleculin Biotech from $45.00 to $20.00 and […]